SS

Sekar Sutha

Active Director Director DIN 03561848
DIN 03561848 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2011
Shareholding value •••• Premium profile

About Sekar Sutha

Data last updated:

Sekar Sutha is a Director at Arsun Healthcare Private Limited (since 2011). The company operates in Pharma. Arsun Healthcare Private Limited reported revenue of ₹4.01 Cr (FY 2025).

DIN 03561848
Primary Designation Director
Industry Pharma
First Appointment 01 Jul 2011
Oldest Company Age 15 yrs
Largest company Arsun Healthcare Private Limited · ₹4.01 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arsun Healthcare Private Limited U74999TZ2011PTC016905
Director01 Jul 20112011₹4.01 Cr (FY 2025)Active

Board colleagues of Sekar Sutha

Directorship timeline

Open interactive timeline →
Arsun Healthcare Private Limited
Premium access

Shareholding and investment profile for Sekar Sutha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekar Sutha

Sekar Sutha currently holds 1 directorship: Arsun Healthcare Private Limited (Director, since 01 Jul 2011, revenue ₹4.01 Cr (FY 2025)).

Sekar Sutha was first appointed on 01 Jul 2011 as Director at Arsun Healthcare Private Limited.

The current boards of Sekar Sutha's companies include Deepa Ganesan (Arsun Healthcare Private Limited), Manimegalai Namachivayam (Arsun Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available